Finding 1150576 (2024-005)

Significant Deficiency
Requirement
I
Questioned Costs
-
Year
2024
Accepted
2025-08-21
Audit: 364705
Organization: Legacy Medical Care Inc. (IL)

AI Summary

  • Core Issue: Legacy failed to document checks on vendor suspension and debarment before contract agreements.
  • Impacted Requirements: Compliance with federal regulations (2 CFR sections 200.212, 200.318(h), 180.300) regarding vendor eligibility.
  • Recommended Follow-Up: Ensure that all vendor checks on sam.gov are performed and documented prior to contract execution.

Finding Text

Finding 2024-005 – Suspension and debarment Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Coronavirus State and Local Fiscal Recovery Funds; Health Center Program Cluster Assistance Listing Number: 21.027; 93.224/93.527 Pass-Through Entity: Cook County Department of Public Health, N/A Pass-Through Number: None; N/A Award Periods: May 1, 2023-November 30, 2026; July 1, 2021 – June 30, 2023; Type of Finding: Significant deficiency in internal control over compliance Criteria: 2 CFR sections 200.212 and 200.318(h); 2 CFR section 180.300; 48 CFR section 52.209-6 outlines that the non-federal entity must verify that the agency in which it is entering into a contract is not suspended or debarred or otherwise excluded from participating in the transaction. Condition: Legacy did not document that sam.gov was checked prior to entering into a contract with a vendor. Questioned Costs: None. Context: One (1) of two (2) vendors tested within 21.027 and two (2) of two (2) vendors within 93.224/93.527. Cause: Legacy did not create and maintain documentation showing that suspension and debarment had been checked prior to engaging a vendor. Effect: Contracted vendors may be ineligible to receive federal dollars for services performed. Repeat Finding: Yes. Prior Year Finding: 2023-006. Recommendation: We recommend that Legacy check, and document, the use of Sam.gov to verify that a vendor was not suspended, debarred, or otherwise excluded from participating in the transaction prior to entering into a contract. Views of Responsible Officials: There is no disagreement with the audit finding.

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 574129 2024-002
    Material Weakness Repeat
  • 574130 2024-003
    Material Weakness Repeat
  • 574131 2024-004
    Material Weakness
  • 574132 2024-005
    Significant Deficiency
  • 574133 2024-003
    Material Weakness Repeat
  • 574134 2024-005
    Significant Deficiency
  • 1150571 2024-002
    Material Weakness Repeat
  • 1150572 2024-003
    Material Weakness Repeat
  • 1150573 2024-004
    Material Weakness
  • 1150574 2024-005
    Significant Deficiency
  • 1150575 2024-003
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
21.027 Coronavirus State and Local Fiscal Recovery Funds $294,199
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $85,710
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $37,364
93.322 Cdc Partnership: Strengthening Public Health Laboratories $33,792
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated Exchanges $18,289
93.268 Immunization Cooperative Agreements $14,950
93.527 Grants for New and Expanded Services Under the Health Center Program $8,823